Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study watches how kidney drug works in real life

NCT ID NCT05348733

Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study follows over 4,600 adults with chronic kidney disease and type 2 diabetes who are starting finerenone, a drug that helps slow kidney damage. Researchers will collect data from routine doctor visits over 12 months to understand why doctors prescribe it, how long patients stay on it, and any side effects like high potassium levels. The goal is to learn how finerenone is used in real-world settings, not to test the drug itself.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
finerenone (Kerendia)
What this could lead to
If successful, this study could provide doctors with better guidance on how to use finerenone effectively in everyday care for kidney disease and diabetes.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care or other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

4,613 people

The number who actually took part.

Started

Jun 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with a diagnosed of CKD and T2D will be enrolled after the decision for treatment with finerenone has been made by the treating physician.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult participants of all genders (≥18 years old) * Diagnosis of CKD associated with T2D based on assessment by physician. * Treatment according to local marketing authorization, finerenone 20 or 10 mg.Treatment should have been started up to 8 weeks before or after the ICF is signed. * Decision to initiate treatment with finerenone must be made before ICF is signed. * Signed informed consent Exclusion Criteria: * Participation in an investigational trial at any time during the course of this study * Contra-indications according to the local label.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease Type 2 diabetes mellitus

Contacts and locations

Locations

  • AA Medical Research Center

    Flint, Texas, 48504, United States

  • AKDHC Medical Research Servies LLC

    Phoenix, Arizona, 85016, United States

  • Academy of Diabetes Thyroid and Endocrine

    El Paso, Texas, 79935, United States

  • Ardmore Medical Research

    Winston-Salem, North Carolina, 27103, United States

  • Augusta University

    Augusta, Georgia, 30912, United States

  • Bland Clinic

    Greensboro, North Carolina, 27401, United States

  • Care Access Research - Minneapolis

    Minneapolis, Minnesota, 55403, United States

  • Caritas Medical Center

    Stockbridge, Georgia, 30281, United States

  • Clinical Research Stategies Inc

    Houston, Texas, 77090, United States

  • Coastal Medical Research

    Brunswick, Georgia, 31523, United States

  • Dallas Renal Group

    Plano, Texas, 75093, United States

  • DarSalud Care / LifeDOC Research

    Memphis, Tennessee, 38119, United States

  • Gaffney Health Services

    Charlotte, North Carolina, 28205, United States

  • Gulf View Medical

    Port Charlotte, Florida, 33952, United States

  • Hanson Clinical Research Center

    Port Charlotte, Florida, 33952, United States

  • Harrisburg Family Medical Center

    Harrisburg, Arkansas, 72432, United States

  • Healthy Heart Cardiology

    Grand Rapids, Michigan, 49546, United States

  • Herman Clinical Research LLC

    Suwanee, Georgia, 30024, United States

  • Kidney Disease Medical Group

    Glendale, California, 91206, United States

  • Kidney and Hypertension Center of Wabash Valley LLC

    Terre Haute, Indiana, 47804, United States

  • Laurie Tom, MD

    Honolulu, Hawaii, 96813, United States

  • Many Locations

    Multiple Locations, Argentina

  • Many Locations

    Multiple Locations, Belgium

  • Many Locations

    Multiple Locations, Brazil

  • Many Locations

    Multiple Locations, Canada

  • Many Locations

    Multiple Locations, China

  • Many Locations

    Multiple Locations, Denmark

  • Many Locations

    Multiple Locations, Germany

  • Many Locations

    Multiple Locations, Greece

  • Many Locations

    Multiple Locations, Mexico

  • Many Locations

    Multiple Locations, Netherlands

  • Many Locations

    Multiple Locations, Portugal

  • Many Locations

    Multiple Locations, Saudi Arabia

  • Many Locations

    Multiple Locations, Singapore

  • Many Locations

    Multiple Locations, Slovenia

  • Many Locations

    Multiple Locations, South Korea

  • Many Locations

    Multiple Locations, Switzerland

  • Many Locations

    Multiple Locations, Taiwan

  • Many Locations

    Multiple Locations, Thailand

  • Medico

    Chicago, Illinois, 60616, United States

  • Metabolic Research Institute

    West Palm Beach, Florida, 33401, United States

  • MultiCare Endocrinology Specialists Tacoma

    Tacoma, Washington, 98405, United States

  • NECCR Primacare Research, LLC

    Fall River, Massachusetts, 02721, United States

  • Nephrology Associates Northern Illinois and Indiana

    Hinsdale, Illinois, 60521, United States

  • Nephrology Consultants LLC

    Huntsville, Alabama, 35805, United States

  • Nephrology and Hypertension Associates

    Tupelo, Mississippi, 38801, United States

  • Ochsner Medical Foundation

    Slidell, Louisiana, 70461, United States

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii, 96813, United States

  • Panoramic Health

    Providence, Rhode Island, 02904, United States

  • RGV Endocrine Center

    McAllen, Texas, 78503, United States

  • Renal Consultants Medical Group

    Granada Hills, California, 91344, United States

  • Renown Regional Medical Center

    Reno, Nevada, 89502, United States

  • The EnLyv Clinics

    Edison, New Jersey, 08820, United States

  • Tranquil Clinical Research

    Webster, Texas, 77598, United States

  • University of Central Florida College of Medicine

    Orlando, Florida, 32817, United States

  • University of Maryland Midtown Professionals Group Healthcare

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.